Latest filings (excl ownership)
25-NSE
Exchange delisting
25 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Apr 24
EFFECT
Notice of effectiveness
3 Apr 24
424B3
Prospectus supplement
2 Apr 24
S-3
Shelf registration
22 Mar 24
10-K
2023 FY
Annual report
18 Mar 24
8-K
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results
18 Mar 24
8-K
Departure of Directors or Certain Officers
11 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
7 Mar 24
8-K
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
22 Feb 24
8-K
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
21 Feb 24
DEFA14A
Additional proxy soliciting materials
16 Feb 24
DEF 14A
Definitive proxy
24 Jan 24
8-K
Other Events
22 Jan 24
PRE 14A
Preliminary proxy
12 Jan 24
8-K
Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering
22 Dec 23
424B4
Prospectus supplement with pricing info
20 Dec 23
EFFECT
Notice of effectiveness
19 Dec 23
CORRESP
Correspondence with SEC
18 Dec 23
CORRESP
Correspondence with SEC
18 Dec 23
S-1/A
IPO registration (amended)
14 Dec 23
S-1/A
IPO registration (amended)
11 Dec 23
CORRESP
Correspondence with SEC
11 Dec 23
UPLOAD
Letter from SEC
6 Dec 23
S-1/A
IPO registration (amended)
30 Nov 23
8-K
Entry into a Material Definitive Agreement
28 Nov 23
8-K
Other Events
27 Nov 23
8-K
Motus GI Reports Third Quarter 2023 Financial Results
13 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Material Modifications to Rights of Security Holders
2 Nov 23
S-1
IPO registration
20 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
21 Sep 23
8-K
Entry into a Material Definitive Agreement
14 Sep 23
DEFA14A
Additional proxy soliciting materials
7 Sep 23
8-K
Departure of Directors or Certain Officers
6 Sep 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Motus GI Reports Second Quarter 2023 Financial Results
14 Aug 23
ARS
2022 FY
Annual report to shareholders
7 Aug 23
DEFA14A
Additional proxy soliciting materials
7 Aug 23
Latest ownership filings
4
Scott Durbin
13 Mar 24
4
Sonja Nelson
13 Mar 24
4
Gary J Pruden
13 Mar 24
4
Timothy P. Moran
12 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
3
Initial statement of insider ownership
22 Sep 23
SC 13G
Orchestra BioMed Holdings, Inc.
22 Sep 23
4
Scott Durbin
6 Sep 23
3
Scott Durbin
6 Sep 23
3
Ravit Ram
21 Jun 23
3
Elad Amor
21 Jun 23
4
Andrew Lawrence Taylor
11 Feb 22
4
Mark Pomeranz
11 Feb 22
4
Darren Sherman
11 Feb 22
4
Shervin J Korangy
11 Feb 22
4
David P Hochman
11 Feb 22
4
Gary J Pruden
11 Feb 22
4
Sonja Nelson
11 Feb 22
4
Timothy P. Moran
11 Feb 22
4
Shervin J Korangy
7 Jan 22
4
Gary J Pruden
7 Jan 22
4
David P Hochman
7 Jan 22
4
Sonja Nelson
7 Jan 22
4
Darren Sherman
7 Jan 22
SC 13G/A
FEINBERG LARRY N
29 Dec 21
4
Andrew Lawrence Taylor
22 Nov 21
4
Mark Pomeranz
22 Nov 21
4
Timothy P. Moran
22 Nov 21
4
Sonja Nelson
23 Jun 21
3
Sonja Nelson
23 Jun 21
4
SAMUEL R MD NUSSBAUM
19 Feb 21
4
Gary J Pruden
19 Feb 21
4
Darren Sherman
19 Feb 21
4
Mark Pomeranz
19 Feb 21
4
Timothy P. Moran
19 Feb 21
4
David P Hochman
19 Feb 21
4
Shervin J Korangy
19 Feb 21
4
Andrew Lawrence Taylor
19 Feb 21
4/A
Andrew Lawrence Taylor
19 Feb 21
SC 13G/A
FEINBERG LARRY N
16 Feb 21